Skip to main content
NANO MRNA Co.,Ltd. logo

NANO MRNA Co.,Ltd. — Investor Relations & Filings

Ticker · 4571 ISIN · JP3651120002 LEI · 529900L2VA2GIFZQTG17 T Professional, scientific and technical activities
Open in API
Filings indexed 70 across all filing types
Latest filing 2021-06-25 Audit Report / Informat…
Country JP Japan
Listing T 4571

About NANO MRNA Co.,Ltd.

https://www.nanomrna.co.jp/

NANO MRNA Co., Ltd. is a biotechnology firm that operates as a platform company and an IP Generator specializing in mRNA-based medicine. The company focuses on creating and out-licensing intellectual property for novel therapeutics by connecting drug discovery seeds with medical and development needs. It leverages a proprietary drug delivery system (DDS) based on micellar nanoparticle technology to advance its pipeline. Key clinical programs include an mRNA therapy for osteoarthritis (RUNX1 mRNA) and an antisense oligonucleotide (ASO) for glioblastoma (TUG1 ASO). Evolving from its predecessor, NanoCarrier, the company combines a legacy of R&D in nanoparticle technology with a strategic focus on RNA drug discovery. It also co-developed and markets Comlex®, an antibacterial agent for ear, nose, and throat conditions.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 95% confidence The document is a 'Confirmation Letter' (確認書) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory document filed alongside the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the report's contents. Since it is a regulatory filing required by law to accompany the annual report and does not fit into the specific categories of financial reports or announcements, it is classified as a Regulatory Filing (RNS). FY 2021
2021-06-25 Japanese
内部統制報告書－第25期(令和2年4月1日－令和3年3月31日)
Governance Information Classification · 100% confidence The document is an 'Internal Control Report' (内部統制報告書) filed under the Financial Instruments and Exchange Act (金融商品取引法) in Japan. This type of report details the company's internal control framework, evaluation scope, and results regarding financial reporting. It is a specific regulatory requirement for Japanese listed companies, distinct from a full Annual Report (10-K) or a simple announcement. Since it is a formal regulatory filing regarding internal controls and does not fit into the other specific categories like M&A or Dividend notices, it is classified as a Regulatory Filing.
2021-06-25 Japanese
有価証券報告書－第25期(令和2年4月1日－令和3年3月31日)
Annual Report Classification · 100% confidence The document is a 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, business descriptions, and management analysis for the fiscal year ending March 31, 2021. It is a formal regulatory filing submitted to the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. FY 2021
2021-06-25 Japanese
四半期報告書－第25期第3四半期(令和2年10月1日－令和2年12月31日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for NanoCarrier Co., Ltd., covering the third quarter of the 25th fiscal period (October 1, 2020, to December 31, 2020). It contains detailed financial statements, including the balance sheet and income statement, and is filed in accordance with the Financial Instruments and Exchange Act of Japan. As it provides comprehensive financial data for an interim period, it is classified as an Interim/Quarterly Report. 9M 2021
2021-02-10 Japanese
四半期報告書－第25期第2四半期(令和2年7月1日－令和2年9月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis, and business updates for the second quarter of the fiscal year ending March 31, 2021. It is a comprehensive financial report rather than an announcement or a summary, fitting the definition of an Interim/Quarterly Report (IR). H1 2021
2020-11-12 Japanese
四半期報告書－第25期第1四半期(令和2年4月1日－令和2年6月30日)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including the balance sheet and income statement for the first quarter of the 25th fiscal period (April 1, 2020, to June 30, 2020), as well as management analysis and notes. This fits the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-08-12 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.